These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29897132)

  • 1. Association between proton pump inhibitors and the risk of hepatocellular carcinoma.
    Shao YJ; Chan TS; Tsai K; Wu SY
    Aliment Pharmacol Ther; 2018 Aug; 48(4):460-468. PubMed ID: 29897132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton Pump Inhibitors and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B or C.
    Kao WY; Su CW; Chia-Hui Tan E; Lee PC; Chen PH; Tang JH; Huang YH; Huo TI; Chang CC; Hou MC; Lin HC; Wu JC
    Hepatology; 2019 Mar; 69(3):1151-1164. PubMed ID: 30175498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
    Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
    Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVES.
    Li DK; Yan P; Abou-Samra AB; Chung RT; Butt AA
    Aliment Pharmacol Ther; 2018 Jan; 47(2):246-258. PubMed ID: 29105111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study.
    Tsai CF; Chen MH; Wang YP; Chu CJ; Huang YH; Lin HC; Hou MC; Lee FY; Su TP; Lu CL
    Gastroenterology; 2017 Jan; 152(1):134-141. PubMed ID: 27639806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of proton pump inhibitors and the risk of hepatocellular carcinoma: A systematic review and meta-analysis.
    Chang TE; Huang YS; Perng CL; Huang YH; Hou MC
    J Chin Med Assoc; 2019 Oct; 82(10):756-761. PubMed ID: 31335628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Risk of Epilepsy after Long-term Proton Pump Inhibitor Therapy.
    Liang CS; Bai YM; Hsu JW; Huang KL; Ko NY; Tsai CK; Yeh TC; Chu HT; Tsai SJ; Chen TJ; Chen MH
    Seizure; 2021 Apr; 87():88-93. PubMed ID: 33735722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton Pump Inhibitors Are Associated with Increased Risk of Psoriasis: A Nationwide Nested Case-Control Study.
    Li CY; Dai YX; Chang YT; Bai YM; Tsai SJ; Chen TJ; Chen MH
    Dermatology; 2021; 237(6):884-890. PubMed ID: 34474411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of cyclooxygenase inhibitor and the risk of hepatocellular carcinoma in patients with chronic hepatitis B: A nested case-control study using a nationwide population-based data.
    Cho KS; Sohn W; Lee YC; Chi SA; Cho JY; Kim K; Paik YH
    J Viral Hepat; 2020 Jan; 27(1):68-73. PubMed ID: 31505085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton-pump inhibitors are associated with an increased risk of asthma: A nationwide nested case-control study.
    Wang WT; Li CY; Chang YT; Bai YM; Tsai SJ; Chen TJ; Chiou SH; Chen MH
    Allergy Asthma Proc; 2023 Sep; 44(5):345-353. PubMed ID: 37641222
    [No Abstract]   [Full Text] [Related]  

  • 12. Proton pump inhibitors and risk of periampullary cancers--A nested case-control study.
    Chien LN; Huang YJ; Shao YH; Chang CJ; Chuang MT; Chiou HY; Yen Y
    Int J Cancer; 2016 Mar; 138(6):1401-9. PubMed ID: 26488896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection.
    Tsan YT; Lee CH; Ho WC; Lin MH; Wang JD; Chen PC
    J Clin Oncol; 2013 Apr; 31(12):1514-21. PubMed ID: 23509319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.
    Lin SM; Yang SH; Liang CC; Huang HK
    Osteoporos Int; 2018 Jan; 29(1):153-162. PubMed ID: 29032384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton Pump Inhibitor Exposure and Acute Myocardial Infarction Risk: A Nested Cohort Study.
    Tseng HJ; Cheng CM; Tsai SJ; Lin WC; Bai YM; Tsai CF; Su TP; Li CT; Chen TJ; Chen MH
    Cardiovasc Toxicol; 2021 Jun; 21(6):444-450. PubMed ID: 33625647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of proton pump inhibitors and risk of rosacea: A nationwide population-based study.
    Dai YX; Tai YH; Chen CC; Chang YT; Chen TJ; Chen MH
    J Dermatol; 2020 Oct; 47(10):1126-1130. PubMed ID: 32613686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population: A Nationwide Population-Based Study.
    Wang YF; Chen YT; Luo JC; Chen TJ; Wu JC; Wang SJ
    Am J Gastroenterol; 2017 Jul; 112(7):1084-1093. PubMed ID: 28397874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do renin-angiotensin system inhibitors reduce risk for hepatocellular carcinoma?: A nationwide nested case-control study.
    Kim KM; Roh JH; Lee S; Yoon JH
    Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101510. PubMed ID: 33272886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Viral Hepatitis Signifies the Association of Premixed Insulin Analogues with Liver Cancer Risks: A Nationwide Population-Based Study.
    Chiang CH; Kuo CS; Lin WW; Su JH; Chen JD; Huang KC
    Int J Environ Res Public Health; 2019 Jun; 16(12):. PubMed ID: 31200528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma.
    Lee MH; Yang HI; Lu SN; Jen CL; You SL; Wang LY; L'Italien G; Chen CJ; Yuan Y;
    Int J Cancer; 2014 Sep; 135(5):1119-26. PubMed ID: 24482200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.